Brief: Kezar Life Sciences Reports Q1 2022 Results

Kezar Life Sciences

12/05/2022 21:51

May 12 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR LIFE SCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED$0.26
    * Q1 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw7MtBypa 
Further company coverage:  KZR.O 

 ((Reuters.Briefs@thomsonreuters.com;))